CK
PJP icon

Carnick & Kubik’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Carnick & Kubik’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.59M Buy
26,443
+879
+3% +$53.8K 0.48% 31
2015
Q4 		$1.79M Buy
25,564
+2,652
+12% +$188K 1.15% 18
2015
Q3 		$1.52M Buy
22,912
+708
+3% +$55.1K 1.06% 17
2015
Q2 		$1.74M Buy
22,204
+120
+0.5% +$9.34K 1.42% 16
2015
Q1 		$1.69M Sell
22,084
-17,700
-44% -$1.3M 1.41% 16
2014
Q4 		$2.65M Buy
39,784
+970
+2% +$64.6K 2.25% 7
2014
Q3 		$2.47M Buy
38,814
+1,110
+3% +$68.5K 2.27% 7
2014
Q2 		$2.3M Buy
37,704
+350
+0.9% +$20.3K 2.3% 8
2014
Q1 		$2.12M Buy
37,354
+12,809
+52% +$727K 2.01% 8
2013
Q4 		$1.31M Buy
24,545
+55
+0.2% +$2.75K 1.19% 19
2013
Q3 		$1.13M Buy
24,490
+140
+0.6% +$6.39K 1.72% 16
2013
Q2 		$1.03M Buy
+24,350
New +$1.01M 1.27% 29

Other funds holding PJP

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Carnick & Kubik's PJP Position: Q1 2016 in Review

Carnick & Kubik increased its Invesco Pharmaceuticals ETF (PJP) stake by 3.4% in Q1 2016, buying an estimated $53.8K and bringing the position to 26,443 shares worth $1.59M. The position accounts for 0.48% of the portfolio, ranked #31.

Carnick & Kubik first reported a position in PJP in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.65M in Q4 2014. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

  • Carnick & Kubik held 26,443 shares of Invesco Pharmaceuticals ETF worth $1.59M as of Q1 2016.
  • Carnick & Kubik bought 879 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $53.8K.
  • Invesco Pharmaceuticals ETF made up 0.48% of Carnick & Kubik's portfolio in Q1 2016, its #31 holding.
  • Carnick & Kubik first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 12 quarters since.
  • Carnick & Kubik's Invesco Pharmaceuticals ETF position peaked at $2.65M in Q4 2014.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.